Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2013-03-06 Capital/Financing Update
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 95% confidence The document is a preliminary prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act of 1933. It includes detailed information about a common stock offering, underwriting, risk factors, use of proceeds, and company business description. The document is clearly related to a securities offering and capital raising activity. It is not an annual or quarterly report, audit report, earnings release, or any other type of financial or governance report. The presence of terms like "prospectus supplement," "offering," "underwriting," and references to registration statements and SEC rules indicate this is a capital/financing update document. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence score.
2013-03-06 English
Major Shareholding Notification 2013
Major Shareholding Notification
2013-02-15 English
FORM 10-Q
Interim / Quarterly Report Q3 2013
2013-02-13 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 13, 2013, reporting the issuance of a press release announcing financial results for the fiscal quarter ended December 31, 2012. The text explicitly states that the press release is furnished as an exhibit and that the information is not deemed "filed" for certain regulatory purposes. The document is short (3927 characters) and primarily serves as a current report to announce the financial results release, not the full financial report itself. There are no detailed financial statements or substantive financial data within this text, only a reference to the press release. According to the classification rules, such a document is best classified as a Regulatory Filing (RNS) because it is a current report announcing an event rather than the full earnings release or quarterly report itself.
2013-02-13 English
OWNERSHIP DOCUMENT
Director's Dealing
2013-02-05 English
NOTICE AND PROXY STATEMENT
Proxy Solicitation & Information Statement
2013-02-05 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.